Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09.08. | Prostatype Genomics AB: Prostatype Genomics publishes prospectus due to upcoming preferential rights issue of units | 72 | GlobeNewswire (Europe) | 9 August 2024 | Prostatype Genomics AB
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, GREAT BRITAIN, HONG... ► Artikel lesen | |
09.08. | Ascelia Pharma AB: Ascelia Pharma Announces Final Terms of Rights Issue | 80 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE... ► Artikel lesen | |
09.08. | Esprit wird endgültig dichtgemacht | 1 | Finance Magazin | ||
09.08. | M&A-Deals: Hugo Boss, KKR, Thyssenkrupp | 2 | Finance Magazin | ||
09.08. | Harfang Exploration Inc. Agrees to Acquire NewOrigin Gold Corp. to Consolidate Casa Berardi Trend Assets in Ontario | 44 | GlobeNewswire (Europe) | MONTREAL and TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) ("Harfang") and NewOrigin Gold Corp. (TSX.V: NEWO) ("NewOrigin") are pleased to announce that they have... ► Artikel lesen | |
09.08. | Ascot Resources Ltd.: Ascot Reports Second Quarter 2024 Results | 379 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) ("Ascot" or the "Company") is pleased to announce the Company's unaudited financial results... ► Artikel lesen | |
09.08. | Nasdaq, Inc.: Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2024 | 226 | GlobeNewswire (Europe) | NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of July 31, 2024, short interest in 3,043 Nasdaq Global MarketSM securities totaled 11,985,723,964 shares compared with... ► Artikel lesen | |
09.08. | Constellation Software Inc. Announces Results for the Second Quarter Ended June 30, 2024 and Declares Quarterly Dividend | 152 | GlobeNewswire (Europe) | TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) ("Constellation" or the "Company") today announced its financial results for the second quarter ended June 30, 2024... ► Artikel lesen | |
09.08. | Helios Fairfax Partners Corporation: Financial Results for the Second Quarter of 2024 | 266 | GlobeNewswire (Europe) | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced... ► Artikel lesen | |
09.08. | Emerita Resources Corp.: Emerita Announces AGM Results | 139 | GlobeNewswire (Europe) | TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX - V: EMO; OTCQB: EMOTF; FSE: LLJA) (the "Company" or "Emerita") is pleased to report that the nominees listed in the management... ► Artikel lesen | |
09.08. | ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update | 1.339 | GlobeNewswire (Europe) | KEY HIGHLIGHTS Phase 2a clinical trial for Cholesterol Efflux Mediator VAR 200 in patients with diabetic kidney disease on track to begin H2-2024.Obesity with related metabolic complications selected... ► Artikel lesen | |
09.08. | Trump Media & Technology Group: TMTG Reports Second Quarter 2024 Results, Closes TV Streaming Deal | 562 | GlobeNewswire (Europe) | ~ Ends Second Quarter with $344 Million Cash on Balance Sheet and No Debt ~ ~ Opens First Data Center to Power Custom-Built Content Delivery Network ~ ~ Adds TV Streaming Platform to Truth Social... ► Artikel lesen | |
09.08. | Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 146 | GlobeNewswire (Europe) | CAMBRIDGE, Mass., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives... ► Artikel lesen | |
09.08. | Belite Bio, Inc: Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update | 616 | GlobeNewswire (Europe) | Tinlarebant, a novel oral therapy, is intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration... ► Artikel lesen | |
09.08. | Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination | 128 | GlobeNewswire (Europe) | NEW YORK, NEW YORK,, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust... ► Artikel lesen | |
09.08. | Edesa Biotech, Inc.: Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results | 187 | GlobeNewswire (Europe) | TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases... ► Artikel lesen | |
09.08. | Artisan Partners Asset Management Inc. Reports July 2024 Assets Under Management | 294 | GlobeNewswire (Europe) | MILWAUKEE, Wis., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of July 31, 2024 totaled... ► Artikel lesen | |
09.08. | INFINT Acquisition Corporation Announces Intention to Voluntarily Delist from NYSE American LLC, Conditional Upon Consummation of its Pending Business Combination with Seamless Group Inc. | 129 | GlobeNewswire (Europe) | NEW YORK, NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- INFINT Acquisition Corporation (the "Company") today announced that, in connection with its proposed business combination (the "Business Combination")... ► Artikel lesen | |
09.08. | Serina Therapeutics, Inc.: Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights | 779 | GlobeNewswire (Europe) | HUNTSVILLE, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics ("Serina") (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform drug delivery technology... ► Artikel lesen | |
09.08. | Motorsport Games Inc.: Motorsport Games Reports Second Quarter 2024 Financial Results | 574 | GlobeNewswire (Europe) | MIAMI, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) ("Motorsport Games" or "the Company") today reported financial results for its second quarter ended June 30, 2024. The... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
VARTA | 2.024 |
EVOTEC | 1.368 |
BAYER | 1.236 |
NVIDIA | 1.205 |
BYD | 1.149 |
NEL | 917 |
TUI | 912 |
TESLA | 782 |
SUPER MICRO COMPUTER | 569 |
DEUTSCHE BANK | 540 |
COMMERZBANK | 534 |
RHEINMETALL | 445 |
DEUTSCHE TELEKOM | 391 |
VOLKSWAGEN | 382 |
JINKOSOLAR | 374 |
AIXTRON SE | 373 |
DEUTSCHE LUFTHANSA | 371 |
BIONTECH | 359 |
PALANTIR TECHNOLOGIES | 357 |
RWE | 343 |
MERCEDES-BENZ | 342 |
STANDARD LITHIUM | 336 |
MUTARES | 328 |
PLUG POWER | 327 |
MICROSTRATEGY | 310 |